Actively Recruiting
MRI-Eye Tracking Pairing to Assess Social Cognition Development in Children and Young Adults With Autism Spectrum Disorder
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-05-28
68
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying social cognition development in children and young adults with Autism Spectrum Disorder (ASD) aged 10 to 20 years. The study aims to improve the assessment of joint attention, a key social skill, by using a new approach that combines functional MRI (fMRI) and eye-tracking to create more realistic visual environments. This method will help explore how perception of joint attention changes over time in autistic individuals compared to typically developing peers. Participants include two groups: those with ASD and a control group with typical development. Both groups undergo MRI and eye-tracking assessments that mimic real social interactions through video-based visual stimuli. This study is non-randomized and observational, focusing on comparing brain and eye movement responses between groups to better understand neurodevelopmental differences. During the study, participants will complete cognitive evaluations, including IQ tests, and undergo MRI and eye-tracking sessions. Researchers will measure differences in brain mapping and eye movements related to joint attention between groups in a single-day assessment. Safety monitoring includes screening for MRI contraindications, and participants must provide informed consent. The total participation time is mainly a single day for these assessments.
CONDITIONS
Brief Title
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 10 to 20 years old
- Diagnosis of Autism Spectrum Disorder (CARS score 6) 30 or higher for the ASD group
- Diagnosis of typical development (CARS score less than 30) for the control group
- IQ test evaluation performed by a trained psychologist
- Obtaining informed oral and written consent from participant and legal guardian
- Affiliated with social security
- No contraindication to magnetic resonance imaging
You will not qualify if you...
- Age outside the range of 10 to 20 years
- Contraindications to MRI such as claustrophobia, pacemaker, or metal implants
- Major obesity exceeding 140 kg preventing MRI tunnel entry
- Pregnancy or breastfeeding
- Under legal guardianship or deprived of liberty
- For control group: psychiatric disorders like ADHD, depression, bipolar disorder, schizophrenia
- For control group: neurological history such as epilepsy or neurovascular accident
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo MRI and Eye Tracking assessments to evaluate social cognition.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
CHU Amiens Picardie
Amiens, Picardie, France, 80054
Actively Recruiting
Research Team
J
Jean-Marc Constans, Pr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here